What is ÉQUILIBRE ARTICULAIRE Sachets?
ÉQUILIBRE ARTICULAIRE Sachets is partly composed of glucosamine and chondroitin, two natural constituents of cartilage, and Horsetail extracts with remineralising effects.
- Instructions of use
It is advisable to take 1 sachet per day, diluted in a glass of water or fruit juice at mealtimes.
As a 3-month course of treatment to be repeated.
- Precautions of use
- Do not exceed the recommended daily dose.
- Store in a cool, dry place, away from light and heat.
- Do not substitute food supplements for a varied and balanced diet.
- To be taken as part of a healthy lifestyle.
- Not recommended for children, teenagers, pregnant or breastfeeding women.
- Keep out of reach of young children.
- Not recommended for diabetics, asthmatics or people treated with antivitamins K.
- Not recommended for people allergic to shellfish or insects.
- Not recommended for people controlling their sodium, potassium or calcium intake.
Nutritional Value :
Daily intake for 1 packet
1 100 mg
Horsetail extract (aerial parts)
* Nutrional Reference Values
Glucosamine sulphate, Chondroitin sulphate, cane sugar, dry extracts of Horsetail aerial parts (Equisetum arvense) and Bamboo exudate (Bambusa bambos), natural orange flavour, ascorbic acid (Vitamin C), acidity corrector: citric acid, cholecalciferol (Vitamin D).
Contains shellfish derivatives.
This list of ingredients is subject to change, please consult the packaging of the product purchased.
- More information
What is glucosamine?
Glucosamine is a natural constituent of connective tissue, cartilage and ligaments. Produced naturally by our body from food, the production of this substance tends to decrease with age or due to certain joint pathologies.
Glucosamine as such is not found in our diet, but our body synthesises it from the glucose (sugar) and glutamine (amino acid) contained in our food*.
If your body does not produce enough glucosamine, it may be advisable to take glucosamine as a supplement. Glucosamine is often synthesised from chitin, a substance extracted from the shells of crustaceans (crabs, crayfish, lobsters, prawns) and consumed in the form of capsules, tablets or powder.
What is chondroitin?
Chondroitin is an essential constituent of cartilage. It is naturally produced by the body. Chondroitin is also found in bones, skin, cornea and artery membranes.
Metanalysis shows that chondroitin is involved in the formation and maintenance of cartilage tissue*. The role of this tissue is to ensure the retention of water in the cartilage and its elasticity, as well as the strength and flexibility of the joints.
What do the studies say about chondroitin?
The roles of chondroitin are similar to those of glucosamine as it is also an essential component of the cartilage naturally produced by the body.
A team of researchers has studied the possible role of glucosamine and chondroitin in helping to relieve the pain of osteoarthritis. According to them, chondroitin helps rebuild cartilage and reduces the action of the enzyme responsible for its destruction, hyaluronidase. It also acts on the formation of cartilage and synovial fluid*.
Chondroitin also helps to slow down the degeneration of joint tissue. It could act against osteoclasts, which are cells that play an important role in the loss of bone substance.
Glucosamine and chondroitin have different properties and some studies have shown beneficial effects when combined**.
What are the properties of horsetail and Boswellia on the joints?
Horsetail is a perennial plant growing on humid and sandy soils in Europe, North Africa and Asia. Horsetail has an exceptional silicon content: 80% of its ashes are said to contain silica.
The Boswellia is a tree of Indian origin of the Burseraceae family. Boswellia resin has been used in India, China and North Africa for thousands of years.
* Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003 Jul 14;163(13):1514-22.
** Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med. 1999 Feb;164(2):85-91.
*** Translated with www.DeepL.com/Translator (free version) ***